Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 287

1.

Focus on Formononetin: Anticancer Potential and Molecular Targets.

Ong SKL, Shanmugam MK, Fan L, Fraser SE, Arfuso F, Ahn KS, Sethi G, Bishayee A.

Cancers (Basel). 2019 May 1;11(5). pii: E611. doi: 10.3390/cancers11050611. Review.

2.

Brassinin Represses Invasive Potential of Lung Carcinoma Cells through Deactivation of PI3K/Akt/mTOR Signaling Cascade.

Yang MH, Lee JH, Ko JH, Jung SH, Sethi G, Ahn KS.

Molecules. 2019 Apr 22;24(8). pii: E1584. doi: 10.3390/molecules24081584.

3.

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB.

Pharmacol Res. 2019 Jun;144:192-209. doi: 10.1016/j.phrs.2019.04.004. Epub 2019 Apr 17. Review.

PMID:
31002949
4.

Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells.

Hwang ST, Kim C, Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, Sethi G, Ahn KS.

Phytomedicine. 2019 Jun;59:152907. doi: 10.1016/j.phymed.2019.152907. Epub 2019 Mar 31.

PMID:
30981183
5.

Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.

Varughese RS, Lam WS, Marican AABH, Viganeshwari SH, Bhave AS, Syn NL, Wang J, Wong AL, Kumar AP, Lobie PE, Lee SC, Sethi G, Goh BC, Wang L.

Cancer. 2019 Jun 1;125(11):1789-1798. doi: 10.1002/cncr.32069. Epub 2019 Apr 1. Review.

PMID:
30933320
6.

Role of Natural Products in Modulating Histone Deacetylases in Cancer.

Merarchi M, Sethi G, Shanmugam MK, Fan L, Arfuso F, Ahn KS.

Molecules. 2019 Mar 16;24(6). pii: E1047. doi: 10.3390/molecules24061047. Review.

7.

Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Mishra S, Verma SS, Rai V, Awasthee N, Chava S, Hui KM, Kumar AP, Challagundla KB, Sethi G, Gupta SC.

Cell Mol Life Sci. 2019 May;76(10):1947-1966. doi: 10.1007/s00018-019-03053-0. Epub 2019 Mar 16. Review.

PMID:
30879091
8.

Pleiotropic Pharmacological Actions of Capsazepine, a Synthetic Analogue of Capsaicin, against Various Cancers and Inflammatory Diseases.

Yang MH, Jung SH, Sethi G, Ahn KS.

Molecules. 2019 Mar 12;24(5). pii: E995. doi: 10.3390/molecules24050995. Review.

9.

Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells.

Ko JH, Um JY, Lee SG, Yang WM, Sethi G, Ahn KS.

J Cell Physiol. 2019 Mar 9. doi: 10.1002/jcp.28456. [Epub ahead of print]

PMID:
30851074
10.

Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.

Loh CY, Arya A, Naema AF, Wong WF, Sethi G, Looi CY.

Front Oncol. 2019 Feb 21;9:48. doi: 10.3389/fonc.2019.00048. eCollection 2019. Review.

11.

Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade.

Lee JH, Kim C, Um JY, Sethi G, Ahn KS.

Cancers (Basel). 2019 Feb 22;11(2). pii: E254. doi: 10.3390/cancers11020254.

12.

FBXW7 in Cancer: What Has Been Unraveled Thus Far?

Sailo BL, Banik K, Girisa S, Bordoloi D, Fan L, Halim CE, Wang H, Kumar AP, Zheng D, Mao X, Sethi G, Kunnumakkara AB.

Cancers (Basel). 2019 Feb 19;11(2). pii: E246. doi: 10.3390/cancers11020246. Review.

13.

Potential of Zerumbone as an Anti-Cancer Agent.

Girisa S, Shabnam B, Monisha J, Fan L, Halim CE, Arfuso F, Ahn KS, Sethi G, Kunnumakkara AB.

Molecules. 2019 Feb 18;24(4). pii: E734. doi: 10.3390/molecules24040734. Review.

14.

Targeting autophagy using natural compounds for cancer prevention and therapy.

Deng S, Shanmugam MK, Kumar AP, Yap CT, Sethi G, Bishayee A.

Cancer. 2019 Apr 15;125(8):1228-1246. doi: 10.1002/cncr.31978. Epub 2019 Feb 12. Review.

PMID:
30748003
15.

Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.

Mandal S, Arfuso F, Sethi G, Dharmarajan A, Warrier S.

Int J Biochem Cell Biol. 2019 May;110:59-69. doi: 10.1016/j.biocel.2019.02.001. Epub 2019 Feb 6.

PMID:
30735730
16.

Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.

Liu Y, Xu X, Lin P, He Y, Zhang Y, Cao B, Zhang Z, Sethi G, Liu J, Zhou X, Mao X.

J Biol Chem. 2019 Mar 22;294(12):4572-4582. doi: 10.1074/jbc.RA118.006057. Epub 2019 Feb 4.

PMID:
30718275
17.

Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements.

Aggarwal V, Kashyap D, Sak K, Tuli HS, Jain A, Chaudhary A, Garg VK, Sethi G, Yerer MB.

Int J Mol Sci. 2019 Feb 2;20(3). pii: E656. doi: 10.3390/ijms20030656. Review.

18.

Arctiin is a pharmacological inhibitor of STAT3 phosphorylation at tyrosine 705 residue and potentiates bortezomib-induced apoptotic and anti-angiogenic effects in human multiple myeloma cells.

Lee JH, Kim C, Lee J, Um JY, Sethi G, Ahn KS.

Phytomedicine. 2019 Mar 1;55:282-292. doi: 10.1016/j.phymed.2018.06.038. Epub 2018 Aug 11.

PMID:
30668440
19.

The expanding roles of long non-coding RNAs in the regulation of cancer stem cells.

Ma Z, Wang YY, Xin HW, Wang L, Arfuso F, Dharmarajan A, Kumar AP, Wang H, Tang FR, Warrier S, Tergaonkar V, Sethi G.

Int J Biochem Cell Biol. 2019 Mar;108:17-20. doi: 10.1016/j.biocel.2019.01.003. Epub 2019 Jan 7.

PMID:
30630112
20.

Oxymatrine Attenuates Tumor Growth and Deactivates STAT5 Signaling in a Lung Cancer Xenograft Model.

Jung YY, Shanmugam MK, Narula AS, Kim C, Lee JH, Namjoshi OA, Blough BE, Sethi G, Ahn KS.

Cancers (Basel). 2019 Jan 7;11(1). pii: E49. doi: 10.3390/cancers11010049.

Supplemental Content

Loading ...
Support Center